![](/images/graphics-bg.png)
Denosumab for the treatment of bisphosphonate resistant hypercalcemia in a hemodialysis patient
Joint Authors
Dahmani, Umar
Sophoclis, Christine
Kebir, Malika
Bouguern, Djemai
Sakho, Abu Bacri
Demarchi, Pascale
Source
Saudi Journal of Kidney Diseases and Transplantation
Issue
Vol. 28, Issue 1 (28 Feb. 2017), pp.154-157, 4 p.
Publisher
Saudi Center for Organ Transplantation
Publication Date
2017-02-28
Country of Publication
Saudi Arabia
No. of Pages
4
Main Subjects
Topics
Abstract EN
The acronym of malignancy, iatrogenic, intoxication and immobilization, sarcoidosis, hyperparathyroidism and hyperthyroidism, milk-alkali syndrome, and paget is very helpful in diagnosing hypercalcemia.
We report on a 94-year-old patient with history of end-stage renal failure secondary to benign nephroangiosclerosis, who was on maintenance hemodialysis during dialysis, his blood chemistry revealed mild hypercalcemia (2.66 mmol / L) with normal level of intact primary hyperparathyroidism (32.37 ng / mL) mandating the discontinuation of Vitamin D3.
In view of persisting hypercalcemia, denosumab 60 mg/mL was administrated subcutaneously.
The serum calcium level showed a decrease and stabilized at near upper limit (2.57 mmol / L).
Three weeks later, the serum calcium remained mildly elevated fluctuating between 2.66 and 2.80 mmol / L.
American Psychological Association (APA)
Dahmani, Umar& Sophoclis, Christine& Kebir, Malika& Bouguern, Djemai& Sakho, Abu Bacri& Demarchi, Pascale. 2017. Denosumab for the treatment of bisphosphonate resistant hypercalcemia in a hemodialysis patient. Saudi Journal of Kidney Diseases and Transplantation،Vol. 28, no. 1, pp.154-157.
https://search.emarefa.net/detail/BIM-748898
Modern Language Association (MLA)
Dahmani, Umar…[et al.]. Denosumab for the treatment of bisphosphonate resistant hypercalcemia in a hemodialysis patient. Saudi Journal of Kidney Diseases and Transplantation Vol. 28, no. 1 (Jan. / Feb. 2017), pp.154-157.
https://search.emarefa.net/detail/BIM-748898
American Medical Association (AMA)
Dahmani, Umar& Sophoclis, Christine& Kebir, Malika& Bouguern, Djemai& Sakho, Abu Bacri& Demarchi, Pascale. Denosumab for the treatment of bisphosphonate resistant hypercalcemia in a hemodialysis patient. Saudi Journal of Kidney Diseases and Transplantation. 2017. Vol. 28, no. 1, pp.154-157.
https://search.emarefa.net/detail/BIM-748898
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 156-157
Record ID
BIM-748898